KRAS and non-small cell lung carcinoma: MK2206 promotes apoptosis through PI3K/AKT/mTOR inhibition; however, a study reported that AKT1 inhibition by MK2206 led to increased invasion and metastasis of NSCLC cells with K-RAS or EGFR mutations [39,40].